{"title":"2013冠心病抗栓治疗进展","authors":"韩雅玲","doi":"10.3760/CMA.J.ISSN.1673-8799.2014.01.002","DOIUrl":null,"url":null,"abstract":"血栓形成是冠状动脉粥样硬化及其并发症的重要因素,也是冠心病事件的始作俑者,抗栓治疗(抗凝、抗血小板治疗)是冠心病治疗的重要基石.实现冠心病抗栓优化治疗,是心血管医师努力的目标之一.一、抗血小板治疗:氯吡格雷仍有一席之地氯吡格雷合用阿司匹林的双联抗血小板方案,因可提高患者远期生存率和降低支架内血栓,已使众多冠心病患者获益.但是,在应用氯吡格雷的过程中发现,患者对氯吡格雷变异性反应较大。","PeriodicalId":64135,"journal":{"name":"中国临床实用医学","volume":"5 1","pages":"2-2"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"2013冠心病抗栓治疗进展\",\"authors\":\"韩雅玲\",\"doi\":\"10.3760/CMA.J.ISSN.1673-8799.2014.01.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"血栓形成是冠状动脉粥样硬化及其并发症的重要因素,也是冠心病事件的始作俑者,抗栓治疗(抗凝、抗血小板治疗)是冠心病治疗的重要基石.实现冠心病抗栓优化治疗,是心血管医师努力的目标之一.一、抗血小板治疗:氯吡格雷仍有一席之地氯吡格雷合用阿司匹林的双联抗血小板方案,因可提高患者远期生存率和降低支架内血栓,已使众多冠心病患者获益.但是,在应用氯吡格雷的过程中发现,患者对氯吡格雷变异性反应较大。\",\"PeriodicalId\":64135,\"journal\":{\"name\":\"中国临床实用医学\",\"volume\":\"5 1\",\"pages\":\"2-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-01-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国临床实用医学\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1673-8799.2014.01.002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国临床实用医学","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1673-8799.2014.01.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
